InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

Current share price for NSB : $0.062 0.008 (11.43%)+

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$24 Letter to Shareholders & Proxy Form 2 Oct 2025 10:15AM $0.160 $0.062 fallen by 61.25%
$24 Notice of Meeting & Proxy Form 2 Oct 2025 10:15AM $0.160 $0.062 fallen by 61.25%
$24 Ceasing to be a substantial holder 19 Sep 2025 8:56AM $0.165 $0.062 fallen by 62.42%
$24 Date of AGM & Closing Date for Director Nominations 16 Sep 2025 9:46AM $0.180 $0.062 fallen by 65.56%
$24 Notification regarding unquoted securities - NSB 16 Sep 2025 9:28AM $0.180 $0.062 fallen by 65.56%
$24 Appendix 4G & Corporate Governance Statement 28 Aug 2025 5:23PM $0.160 $0.062 fallen by 61.25%
$24 2025 Annual Report & Appendix 4E 28 Aug 2025 5:23PM $0.160 $0.062 fallen by 61.25%
$24 Previous StemSmart Studies Support Renal Transplantation 27 Aug 2025 9:49AM $0.165 $0.062 fallen by 62.42%
$24 Presentation - TechKnow Invest Roadshow Conference 19 Aug 2025 8:47AM $0.170 $0.062 fallen by 63.53%
$24 NeuroScientific Partners with Leading Biologic Manufacturer 31 Jul 2025 9:02AM $0.240 $0.062 fallen by 74.17%
$24 Change in substantial holding 30 Jul 2025 10:16AM $0.240 $0.062 fallen by 74.17%
$24 Experienced Cell Therapy Executive Appointed CEO 28 Jul 2025 9:19AM $0.220 $0.062 fallen by 71.82%
$24 Dr Catherine Cole Appointed as Chief Medical Officer 25 Jul 2025 9:19AM $0.230 $0.062 fallen by 73.04%
$24 Quarterly Activities/Appendix 4C Cash Flow Report 23 Jul 2025 9:18AM $0.190 $0.062 fallen by 67.37%
$24 Becoming a substantial holder 10 Jul 2025 3:53PM $0.130 $0.062 fallen by 52.31%
$24 Change in substantial holding 4 Jul 2025 2:13PM $0.130 $0.062 fallen by 52.31%
$24 Change of Director's Interest Notice (AU) 1 Jul 2025 12:50PM $0.120 $0.062 fallen by 48.33%
$24 Breakthrough Stem Cell Tech Acquired-StemSmart Presentation 30 Jun 2025 9:14AM $0.080 $0.062 fallen by 22.50%
$24 StemSmart Acquisition Complete 27 Jun 2025 9:29AM $0.074 $0.062 fallen by 16.22%
$24 Initial Director's Interest Notice x2 27 Jun 2025 9:20AM $0.074 $0.062 fallen by 16.22%
$24 Change of Director's Interest Notice x2 27 Jun 2025 9:16AM $0.074 $0.062 fallen by 16.22%
$24 Final Director's Interest Notice x2 27 Jun 2025 9:13AM $0.074 $0.062 fallen by 16.22%
$24 Section 708A Notice 27 Jun 2025 9:11AM $0.074 $0.062 fallen by 16.22%
$24 Notification regarding unquoted securities - NSB 27 Jun 2025 9:09AM $0.074 $0.062 fallen by 16.22%
$24 Notification regarding unquoted securities - NSB 27 Jun 2025 9:08AM $0.074 $0.062 fallen by 16.22%

26 - 50 of 407 results

Page 2 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.